ArticleFrontiers in genetics2026
A novel multivariate framework for functional gene networks enrichment analysis.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gene network analysis is critically implicated in disease research for uncovering functional modules and interaction-driven pathways underlying biological and disease processes. However, the interpretation of large inferred networks remains challenging. Although functional gene network analysis allows the interpretation of large inferred networks, challenges such as reduction of multiple network-level features to a single composite score often limit their application. This data reduction can mask the important multivariate characteristics of gene networks, hindering efficient differentiation of individual contributions of distinct network components. Hence, this study aimed to investigate a novel computational strategy called Multivariate Framework for Functional Gene Network Enrichment Analysis (mFGNA). This framework incorporated diverse network-level features from a graph-theoretical perspective, including node properties (centrality), edge connectivity patterns (Jaccard distance), interaction strengths (edge weights), alongside traditional expression levels. Notably, mFGNA preserved these multidimensional characteristics, capturing complex rewiring of gene networks across different phenotypic states. Furthermore, mFGNA adopted a gene-level permutation strategy to evaluate the enrichment hypothesis, ensuring effective statistical inference and reduced computational complexity compared with phenotype-based permutations. Extensive Monte Carlo simulations validated mFGNA through both undirected and directed gene networks, showing consistently improved performance over existing approaches across diverse pathway settings. We also applied mFGNA to investigate immune pathway perturbations in cancer cell lines and identified significant network-level dysregulation in pancreatic and non-small cell lung cancers. Cancer-specific interaction modules were dominated by human leukocyte antigen class II genes. Meanwhile, normal cell networks were characterized by hub genes such as MMP1 and MMP3 that were implicated in tissue maintenance, highlighting immune remodeling in tumors and the potential molecular targets for developing diagnostic and therapeutic interventions. Overall, the study shows that mFGNA enables effective functional pathway discovery in complex gene networks, providing mechanistic insights and potential translational targets in disease contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.